SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Selexys Pharmaceuticals Corporation Completes $23 Million Equity Financing and Signs Agreement With Novartis Pharmaceuticals Corporation for Up to $665 Million